Charmacy Pharmaceutical Co., Ltd.

SEHK:2289 株式レポート

時価総額：HK$1.0b

Charmacy Pharmaceutical マネジメント

マネジメント 基準チェック /44

Charmacy Pharmaceuticalの CEO はChuanglong Yaoで、 Mar2000年に任命され、 の在任期間は 24.67年です。 の年間総報酬はCN¥ 728.07Kで、 87.4%給与と12.6%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の31.97%を直接所有しており、その価値はHK$ 319.75M 。経営陣と取締役会の平均在任期間はそれぞれ2.6年と5.7年です。

主要情報

Chuanglong Yao

最高経営責任者

CN¥728.1k

報酬総額

CEO給与比率87.4%
CEO在任期間24.7yrs
CEOの所有権32.0%
経営陣の平均在職期間2.6yrs
取締役会の平均在任期間5.7yrs

経営陣の近況

There Could Be A Chance Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Will Have Their Compensation Increased

May 13
There Could Be A Chance Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Will Have Their Compensation Increased

Recent updates

There Could Be A Chance Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Will Have Their Compensation Increased

May 13
There Could Be A Chance Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Will Have Their Compensation Increased

There's Reason For Concern Over Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) Massive 40% Price Jump

Apr 24
There's Reason For Concern Over Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) Massive 40% Price Jump

Charmacy Pharmaceutical Co., Ltd. (HKG:2289) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jan 19
Charmacy Pharmaceutical Co., Ltd. (HKG:2289) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

These 4 Measures Indicate That Charmacy Pharmaceutical (HKG:2289) Is Using Debt Reasonably Well

Oct 25
These 4 Measures Indicate That Charmacy Pharmaceutical (HKG:2289) Is Using Debt Reasonably Well

If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity

Sep 17
If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity

Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?

May 02
Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?

What Type Of Returns Would Charmacy Pharmaceutical's(HKG:2289) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Mar 15
What Type Of Returns Would Charmacy Pharmaceutical's(HKG:2289) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Are Dividend Investors Making A Mistake With Charmacy Pharmaceutical Co., Ltd. (HKG:2289)?

Feb 17
Are Dividend Investors Making A Mistake With Charmacy Pharmaceutical Co., Ltd. (HKG:2289)?

We Wouldn't Rely On Charmacy Pharmaceutical's (HKG:2289) Statutory Earnings As A Guide

Jan 27
We Wouldn't Rely On Charmacy Pharmaceutical's (HKG:2289) Statutory Earnings As A Guide

Returns On Capital At Charmacy Pharmaceutical (HKG:2289) Paint An Interesting Picture

Jan 09
Returns On Capital At Charmacy Pharmaceutical (HKG:2289) Paint An Interesting Picture

What Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) ROE Can Tell Us

Dec 22
What Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) ROE Can Tell Us

Reflecting on Charmacy Pharmaceutical's (HKG:2289) Share Price Returns Over The Last Three Years

Nov 29
Reflecting on Charmacy Pharmaceutical's (HKG:2289) Share Price Returns Over The Last Three Years

CEO報酬分析

Charmacy Pharmaceutical の収益と比較して、Chuanglong Yao の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

CN¥52m

Mar 31 2024n/an/a

CN¥52m

Dec 31 2023CN¥728kCN¥636k

CN¥51m

Sep 30 2023n/an/a

CN¥74m

Jun 30 2023n/an/a

CN¥96m

Mar 31 2023n/an/a

CN¥93m

Dec 31 2022CN¥732kCN¥638k

CN¥90m

Sep 30 2022n/an/a

CN¥54m

Jun 30 2022n/an/a

CN¥18m

Mar 31 2022n/an/a

CN¥20m

Dec 31 2021CN¥679kCN¥646k

CN¥23m

Sep 30 2021n/an/a

CN¥29m

Jun 30 2021n/an/a

CN¥36m

Mar 31 2021n/an/a

CN¥38m

Dec 31 2020CN¥685kCN¥649k

CN¥41m

Sep 30 2020n/an/a

CN¥35m

Jun 30 2020n/an/a

CN¥29m

Mar 31 2020n/an/a

CN¥34m

Dec 31 2019CN¥714kCN¥650k

CN¥40m

Sep 30 2019n/an/a

CN¥41m

Jun 30 2019n/an/a

CN¥42m

Mar 31 2019n/an/a

CN¥44m

Dec 31 2018CN¥715kCN¥649k

CN¥45m

Sep 30 2018n/an/a

CN¥46m

Jun 30 2018n/an/a

CN¥47m

Mar 31 2018n/an/a

CN¥46m

Dec 31 2017CN¥713kCN¥650k

CN¥45m

報酬と市場: Chuanglongの 総報酬 ($USD 100.54K ) は、 Hong Kong市場 ($USD 232.62K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Chuanglongの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Chuanglong Yao (54 yo)

24.7yrs

在職期間

CN¥728,071

報酬

Mr. Chuanglong Yao has been Chief Executive Officer at Charmacy Pharmaceutical Co., Ltd. since March 2000 and serves as its Vice Chairman since May 31, 2023 and served as its Chairman since May 2015. Mr. Y...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Chuanglong Yao
CEO & Vice Chairman24.7yrsCN¥728.07k31.97%
HK$ 319.7m
Hanzi Zhang
CFO & Executive Director2.6yrsCN¥385.49kデータなし
Yuyan Zheng
VP & Executive Director9.3yrsCN¥991.13kデータなし
Zhijie Lin
Chief Logistics Officer & CTOno dataCN¥188.00kデータなし
Wai Ling Wong
Joint Company Secretary2.6yrsデータなしデータなし
Jiexi Yao
Joint Company Secretary2.6yrsデータなしデータなし

2.6yrs

平均在職期間

45yo

平均年齢

経験豊富な経営陣: 2289の経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Chuanglong Yao
CEO & Vice Chairman24.7yrsCN¥728.07k31.97%
HK$ 319.7m
Hanzi Zhang
CFO & Executive Director2.3yrsCN¥385.49kデータなし
Yuyan Zheng
VP & Executive Director9.5yrsCN¥991.13kデータなし
Chi Wai Wan
Independent Non-Executive Director8.9yrsCN¥144.00kデータなし
Jian Guan
Independent Non-Executive Director8.9yrsCN¥50.00kデータなし
Ling Zhang
Independent Supervisor9.5yrsデータなしデータなし
Xiyue Zheng
Employee Representative Supervisor9.5yrsデータなしデータなし
Hanguo Li
Independent Non-Executive Director1.5yrsCN¥29.30kデータなし
Zheng Fu
Non-Executive Director2.3yrsデータなしデータなし
Jingbin Yan
Non-Executive Chairman2.4yrsデータなしデータなし
Fei Xu
Non-Executive Director1.5yrsデータなしデータなし
Minghong Zhu
Chairman of the Board of Supervisors1.5yrsデータなしデータなし

5.7yrs

平均在職期間

49yo

平均年齢

経験豊富なボード: 2289の 取締役会 は 経験豊富 であると考えられます ( 5.7年の平均在任期間)。